Table 2

Myocardial infarction incidence rates per 10 000 person-year of follow-up by exposure status

VariablesUnexposedILD combinedPSPF
NPYRate* (95% CI)NPYRate* (95% CI)NPYRate* (95% CI)NPYRate* (95% CI)
Overall56 884291 03832.26 (30.26 to 34.39)11 68858 02941.53 (36.60 to 47.12)456831 84616.01 (12.17 to 21.07)712026 18372.57 (62.95 to 83.65)
Sex
 Male31 854151 46940.27 (37.20 to 43.60)629129 19554.12 (46.31 to 63.25)231315 47320.68 (14.63 to 29.24)397813 72291.83 (77.11 to 109.34)
 Female25 030139 56923.57 (21.16 to 26.26)539728 83528.78 (23.21 to 35.69)225516 37311.60 (7.40 to 18.19)314212 46251.36 (40.20 to 65.62)
Age (years)
 <5012 27294 5174.97 (3.74 to 6.62)307522 57610.63 (7.13 to 15.86)269120 2077.92 (4.85 to 12.92)384236933.77 (16.89 to 67.51)
 50–59746048 50516.29 (13.06 to 20.31)175910 83027.70 (19.37 to 39.62)1047709121.15 (12.75 to 35.09)712374040.11 (24.18 to 66.53)
 60–6911 32157.91130.39 (26.22 to 35.23)230810 64363.89 (50.38 to 81.04)568337629.62 (15.94 to 55.04)1740726779.81 (61.71 to 103.24)
 70–7915 39260 34764.63 (58.52 to 71.37)2759944380.48 (64.27 to 100.77)210100489.60 (46.62 to 172.21)2549843979.39 (62.49 to 100.87)
 >8010 43829 75783.01 (73.27 to 94.03)1786453694.79 (70.30 to 127.81)5216859.67 (8.41 to 423.59)1735436996.13 (71.05 to 130.09)
  • *Rate per 10 000 person-years.

  • ILD, inflammatory lung disease; N, number; PF, pulmonary fibrosis; PY, person-years.